These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. In vitro activity of teicoplanin and vancomycin against gram-positive bacteria from human clinical and veterinary sources. Jensen KT, Schønheyder H, Pers C, Thomsen VF. APMIS; 1992 Jun; 100(6):543-52. PubMed ID: 1535201 [Abstract] [Full Text] [Related]
5. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures]. Fajardo Olivares M, Hidalgo Orozco R, Rodríguez Garrido S, Gaona Álvarez C, Sánchez Silos RM, Hernández Rastrollo R, Martínez Tallo E, Cordero Carrasco JL. Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538 [Abstract] [Full Text] [Related]
6. Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital. Sloos JH, van de Klundert JA, Dijkshoorn L, van Boven CP. J Antimicrob Chemother; 1998 Dec; 42(6):787-91. PubMed ID: 10052903 [Abstract] [Full Text] [Related]
8. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs. Vedel G, Leruez M, Lémann F, Hraoui E, Ratovohery D. Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):820-2. PubMed ID: 2150815 [Abstract] [Full Text] [Related]
9. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method. Thamlikitkul V. J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906 [Abstract] [Full Text] [Related]
10. Susceptibility of Brazilian staphylococcal strains to glycopeptides evaluated by different testing methods. Ferreira Nunes AP, Martins Teixeira L, Reis Bastos CC, de Souza Fonseca L, Netto dos Santos KR. Curr Microbiol; 2002 Jun; 44(6):385-90. PubMed ID: 12000986 [Abstract] [Full Text] [Related]
11. In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin. Watanakunakorn C. J Antimicrob Chemother; 1988 Sep; 22(3):321-4. PubMed ID: 2972670 [Abstract] [Full Text] [Related]
12. Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening. Nunes AP, Teixeira LM, Iorio NL, Bastos CC, de Sousa Fonseca L, Souto-Padrón T, dos Santos KR. Int J Antimicrob Agents; 2006 Apr; 27(4):307-15. PubMed ID: 16542825 [Abstract] [Full Text] [Related]
13. In vitro activity of oxacillin, vancomycin and teicoplanin against staphylococci isolated from patients on surgical and coronary intensive care units. Kucukates E, Nalan Karayel E, Gultekin N, Okuyan E, Kansiz E, Gurler N. Int J Antimicrob Agents; 2004 Aug; 24(2):193-4. PubMed ID: 15288323 [No Abstract] [Full Text] [Related]
14. Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides, and molecular epidemiology. Boisson K, Thouverez M, Talon D, Bertrand X. Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):660-5. PubMed ID: 12373498 [Abstract] [Full Text] [Related]
15. Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci. Bourgeois I, Pestel-Caron M, Lemeland JF, Pons JL, Caron F. Antimicrob Agents Chemother; 2007 Feb; 51(2):740-3. PubMed ID: 17116684 [Abstract] [Full Text] [Related]
16. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates]. Hoşgör Limoncu M, Ermertcan S, Taşli H, Kurutepe S. Mikrobiyol Bul; 2007 Oct; 41(4):511-6. PubMed ID: 18173069 [Abstract] [Full Text] [Related]
20. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD. Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446 [Abstract] [Full Text] [Related] Page: [Next] [New Search]